However, we believe that, even though the main results of our study did not reach statistical significance, the observed results in subgroups may still be relevant for clinical practice.
← all excerpts
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.
1
—
—